Hill Raymond George
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/25/2026
Type
OTHER
Addex Therapeutics Ltd
ADXN • Biotechnology
$3.65
▼ -0.06 (-1.62%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$5.21M
Growth
-26.8%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 1.4Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 30, 2026, 12:00 AM UTCLast profile update: Aug 26, 2026, 12:18 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.65
Change-1.62%
Shares Out1.43M
Market Cap$5.21M
52W Range3.73 - 12.05
Beta2.00
P/E-0.80
P/S178.77
P/B1.12
P/FCF-2.58
EV/Sales137.44
EV/EBITDA-0.60
Price$3.65
Change-1.62%
Shares Out1.43M
Market Cap$5.21M
52W Range3.73 - 12.05
Beta2.00
P/E-0.80
P/S178.77
P/B1.12
P/FCF-2.58
EV/Sales137.44
EV/EBITDA-0.60
EV/FCF-1.98
Earnings Yield-125.57%
FCF Yield-38.74%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-93.91%
Profit Margin-224.48%
Debt/Eq0.01
Current Ratio1.40
Quick Ratio1.40
Revenue 5Y-26.77%
Target$30.00
Target Upside721.92%
Target Median$30.00
Target Range30.00 - 30.00
Volume75.08K
Avg Volume2.92K
EPS Surprise-0.51
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
57/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 1.4Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Price Target
2026-08-26
Low
$30.00
Mean
$30.00
Median
$30.00
High
$30.00
Insider Transactions
Recent executive and insider activity
Kalinichev Mikhail
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/25/2026
Type
OTHER
Lawton Vincent Michael
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
03/25/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hill Raymond George | OTHER | 0 | Not reported | 03/18/2026 | 03/25/2026 |
| Kalinichev Mikhail | OTHER | 0 | Not reported | 03/18/2026 | 03/25/2026 |
| Lawton Vincent Michael | OTHER | 0 | Not reported | 03/18/2026 | 03/25/2026 |
| Mills Roger | OTHER | 0 | Not reported | 03/18/2026 | 03/25/2026 |
| Kalinichev Mikhail | OTHER | +200,000 | $0.06 | 08/01/2024 | 03/25/2026 |
| Hill Raymond George | OTHER | +273,107 | $0.06 | 01/08/2024 | 03/25/2026 |
| Teyssedou Lenaic Nathanael | OTHER | +100,485 | $0.06 | 01/08/2024 | 03/25/2026 |
| Lawton Vincent Michael | OTHER | +501,598 | $0.06 | 01/08/2024 | 03/25/2026 |
| Mills Roger | OTHER | +50,000 | $0.06 | 01/08/2024 | 03/25/2026 |
| Teyssedou Lenaic Nathanael | OTHER | +208,974 | $0.06 | 05/12/2023 | 03/25/2026 |
| Teyssedou Lenaic Nathanael | OTHER | +90,529 | $0.17 | 10/05/2022 | 03/25/2026 |
| Manke Isaac | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Nunn Jason Raleigh | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Dyer Timothy Mark | OTHER | 0 | Not reported | 03/18/2026 | 03/18/2026 |
| Manke Isaac | OTHER | +50,000 | $0.06 | 01/08/2024 | 03/18/2026 |
| Nunn Jason Raleigh | OTHER | +50,000 | $0.06 | 01/08/2024 | 03/18/2026 |
| Dyer Timothy Mark | OTHER | +3,369,796 | $0.06 | 01/08/2024 | 03/18/2026 |